Dr. George Koch

kind of jumping on their back a little bit as far as, you know, focusing on the cancer survivorship aspect of some of the things that we do, and then maybe extrapolating that to the more benign processes, I think could be certainly one where we could leverage some things like funding.

But we're certainly behind urologic oncology, I think, in kind of the landscape overall.

I'd love to know what unanswered questions do you think that we need to tackle in the next decade?

Yeah, absolutely.

And, you know, brings you back to the whole reason you got into reconstructive urology, quality of life, you know, patient voice.

Yeah, absolutely.

Thank you so much for joining me today on Backtable Urology, Dr. Breyer.

You're a force in urologic reconstruction.

I loved our talking, our talking shop.

I hope I didn't take up too much time.

I know you're a busy guy, but thank you so much for joining.

This was really wonderful.

Yeah, absolutely.